The UT Research Foundation is pleased to announce the UTRF Drug Discovery Support Program. The goal of the program is to add commercial value to UT technologies by acquiring early stage drugability data (ADME-tox, PK/PD) on small molecules and early development assays for biologics. In order to receive assay support through the program, an invention (read more)
UTRF News
UTRF Drug Discovery Support Program
Summary: For 2013-2014, UTRF has acquired funds to pay for some early stage drugability assays. Purpose: To add commercial value to UTHSC technologies by acquiring early stage drugability data (ADME-tox, PK/PD) on small molecules and early development assays for biologics. Guidelines: In order to request assay support, an invention disclosure must be submitted or have (read more)
UT Research Foundation Names David Washburn Next President
David Washburn has been named president of the University of Tennessee Research Foundation (UTRF), the not-for-profit organization responsible for commercializing technology created by UT faculty. Prior to this appointment, Washburn was vice president of UTRF’s multi-disciplinary office based in Knoxville, which oversees technologies developed at the UT campuses in Knoxville, Chattanooga and Martin; UT Institute (read more)